Roche Thwarts Plaintiffs' Experts In NJ Accutane Litigation

Law360, New York (February 23, 2015, 9:08 PM EST) -- Hoffmann-La Roche Ltd. succeeded Monday in convincing a New Jersey judge to reject the testimony of plaintiffs’ experts who had linked its acne medication Accutane to Crohn's disease, a ruling that could spell the end of thousands of such suits in the consolidated state litigation.

After hearing about two weeks of arguments, Judge Nelson Johnson issued a 34-page opinion rejecting the testimony of the plaintiffs' gastroenterology expert Arthur Kornbluth and biostatistics expert David Madigan, ruling in a biting opinion that they were "cherry picking evidence" and failed to show that they based their views on reliable data.

The ruling sides with...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Law Firms

Companies